-
Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's disease
Baakman, A. C., Gavan, C., van Doeselaar, L., de Kam, M., Broekhuizen, K., Bajenaru, O., Camps, L., Swart, E. L., Kalisvaart, K., Schoonenboom, N., Lemstra, E., Scheltens, P., Cohen, A., van Gerven, J. & Groeneveld, G. J., 28 Dec 2021, (E-pub ahead of print) In: British journal of clinical pharmacology.Research output: Contribution to journal › Article › Academic › peer-review
-
Central nervous system effects of the histamine-3 receptor antagonist CEP-26401, in comparison with modafinil and donepezil, after a single dose in a cross-over study in healthy volunteers
Baakman, A. C., Zuiker, R., van Gerven, J. M. A., Gross, N., Yang, R., Fetell, M., Gershon, A., Gilgun-Sherki, Y., Hellriegel, E. & Spiegelstein, O., 1 May 2019, In: British journal of clinical pharmacology. 85, 5, p. 970-985Research output: Contribution to journal › Article › Academic › peer-review
-
No synergistic effect of subtherapeutic doses of donepezil and EVP-6124 in healthy elderly subjects in a scopolamine challenge model
Baakman, A. C., Alvarez-Jimenez, R., Loewen, G., de Kam, M. L., Broekhuizen, K., Hilt, D. C. & Groeneveld, G. J., 1 Jan 2019, In: Alzheimer's and Dementia: Translational Research and Clinical Interventions. 5, p. 89-98 10 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
